Chronic treatment with haloperidol, a D2-receptor antagonist and a neuroleptic, increases the number of D2-receptors in rat striatum. However, there have been inconsistent reports on the De-receptor mRNA level, one showing the increase in the mRNA level and another detecting no changes. Furthermore, they did not distinguish the two isoforms of D2-receptor, D2A and D2B. In the present work, both D 2-and D2A-receptor mRNA levels in rat striatum were estimated after chronic administration of haloperidol. There was, within the sensitivity of the assay, no significant increase in either of them between 3 and 24 h after the lasl administration. This suggests that chronic haloperidol treatment does not affect the transcriptional regulation of the Dz-receptor gene or the alternative splicing process of its transcripts. After chronic administration of a neuroleptic such as haloperidol, the Dz-receptor density increases in rat striatum 3. Similar up-regulation of the De-receptor level in the striatum was observed after dopamine depletion by chronic treatment with reserpine ~ and after 6-hydroxydopamine lesion of the nigrostriatal pathway 6 which results in denervation of the striatum. It was suggested that the increased D2-receptor level was due to the reduced rate of its turnover ~. More recently, an increase in the levels of Dz-receptor mRNA in the striata of haloperidol-treated rats has been shown by means of in situ hybridization ~3. However, there have been contradictory findings that the
